Report for: FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial

Title	FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial
Published in	Trials, June 2020
DOI	10.1186/s13063-020-04432-w
Pubmed ID	32586344
Authors	Alexandra Poinas, Marie Lemoigne, Sarah Le Naour, Jean-Michel Nguyen, Solène Schirr-Bonnans, Valery-Pierre Riche, Florence Vrignaud, Laurent Machet, Jean-Paul Claudel, Marie-Thérèse Leccia, Ewa Hainaut, Nathalie Beneton, Cécile Dert, Aurélie Boisrobert, Laurent Flet, Anne Chiffoleau, Stéphane Corvec, Amir Khammari, Brigitte Dréno

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	17%
Unknown	5	83%

Type	Count	As %
Members of the public	4	67%
Scientists	1	17%
Practitioners (doctors, other healthcare professionals)	1	17%

Mendeley readers

The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	40	100%

Readers by professional status	Count	As %
Student > Bachelor	7	18%
Student > Master	6	15%
Researcher	3	8%
Student > Doctoral Student	2	5%
Student > Ph. D. Student	2	5%
Other	5	13%
Unknown	15	38%

Readers by discipline	Count	As %
Medicine and Dentistry	14	35%
Pharmacology, Toxicology and Pharmaceutical Science	3	8%
Nursing and Health Professions	3	8%
Biochemistry, Genetics and Molecular Biology	2	5%
Agricultural and Biological Sciences	1	3%
Other	2	5%
Unknown	15	38%

FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial